Presentation
Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 2004;53 Suppl 1:S103-109. [ Links ] 30. Anglin RE, Garside SL, Tarnopolsky MA, Mazurek MF, Rosebush PI. [scielo.org.pe]
Cardiovascular
- Hypertension
Essential hypertension and oxidative stress: new insights. World J Cardiology, 6(6), 353-366. [ Links ] 13. Aroor, A., Mandavia, C., Ren, J., Sowers, J. and Pulakat, L. (2012). [scielo.sa.cr]
Psychiatrical
- Psychiatric Manifestation
The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J Clin Psychiatry. 2012;73(4):506-12. [ Links ] 31. Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC. [scielo.org.pe]
Treatment
Endothelial dysfunction and coronary artery disease: assessment, prognosis and treatment. Coron Artery Dis, 25(8), 713-724. [ Links ] 30. Hadi, H., Carr, C. and Suwaidi, J. (2005). [scielo.sa.cr]
Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS. Biochim Biophys Acta. 2012;1822(6):1019-29. [ Links ] 19. Sproule DM, Kaufmann P. [scielo.org.pe]
Prognosis
Endothelial dysfunction and coronary artery disease: assessment, prognosis and treatment. Coron Artery Dis, 25(8), 713-724. [ Links ] 30. Hadi, H., Carr, C. and Suwaidi, J. (2005). [scielo.sa.cr]
Epidemiology
Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63(2):447-54. [ Links ] 8. [scielo.org.pe]
Prevention
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019;90(5):529-36. [ Links ] 41. Lin C-M, Thajeb P. [scielo.org.pe]